We think that when the serum VEGF-C level is excessive, and excess VEGF-C cannot bind to VEGFR-3 in the cancer cells, it binds to VEGFR-3 in lymph vessels, promoting lymphangiogenesis and lymph node metastasis. This evidence concerns the gene FLT4 and cancer.